Ipilimumab/nivolumabAdrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1973卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45876-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：148 / 148

相关论文

共 50 条

[31] Ipilimumab/levothyroxine sodium/nivolumabHypophysitis, adrenal insufficiency and syncopal episode: case report
Reactions Weekly, 2017, 1652 (1) : 159 - 159
[32] Ipilimumab/nivolumabHypothyroidism, adrenal insufficiency and type I diabetes mellitus: case report
Reactions Weekly, 2020, 1795 (1) : 163 - 163
[33] Ipilimumab/nivolumabDiarrhoea, skin rash, renal insufficiency and ocular rosacea: case report
Reactions Weekly, 2017, 1672 (1) : 147 - 147
[34] Ipilimumab/nivolumab/pembrolizumabAlopecia areata, adrenal insufficiency and lack of efficacy: case report
Reactions Weekly, 2024, 2027 (1) : 244 - 244
[35] Ipilimumab/nivolumabHypophysitis and adrenal insufficiency following off label use: case report
Reactions Weekly, 2019, 1781 (1) : 207 - 207
[36] Ipilimumab/nivolumabLiver dysfunction, cytokine release syndrome and relative adrenal insufficiency: case report
Reactions Weekly, 2024, 2031 (1) : 209 - 209
[37] Ipilimumab/nivolumabHypophysitis leading to adrenal insufficiency and acute colonic pseudo-obstruction: case report
Reactions Weekly, 2023, 1986 (1) : 224 - 224
[38] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1887 (1) : 396 - 396
[39] Ipilimumab/pembrolizumabIleus: case report
Reactions Weekly, 2023, 1956 (1) : 287 - 287
[40] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2021, 1854 (1) : 199 - 199

← 1 2 3 4 5 →